<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>(Biological Terrorism)</title><link>http://www.unboundmedicine.com/medline//research/Biological_Terrorism</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Infectious Disease Surveillance by Medical Examiners and Coroners.</title><link>http://www.unboundmedicine.com/medline/citation/23697772/Infectious_Disease_Surveillance_by_Medical_Examiners_and_Coroners_</link><description><div class="result"><ul><li class="author">Blau DM, Clark SC, Nolte KB </li><li class="title"><a href="./citation/23697772/Infectious_Disease_Surveillance_by_Medical_Examiners_and_Coroners_">Infectious Disease Surveillance by Medical Examiners and Coroners.<span class="title-pubtype"> [LETTER]</span></a></li><li class="source" title="Emerging infectious diseases">Emerg Infect Dis 2013 May; 19(5)</li></ul></div></description></item><item><title>Anthrax threat: a review of clinical and diagnostic measures.</title><link>http://www.unboundmedicine.com/medline/citation/23697023/Anthrax_threat:_a_review_of_clinical_and_diagnostic_measures_</link><description><div class="result"><ul><li class="author">Alqurashi AM </li><li class="title"><a href="./citation/23697023/Anthrax_threat:_a_review_of_clinical_and_diagnostic_measures_">Anthrax threat: a review of clinical and diagnostic measures.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="J Egypt Soc Parasitol">J Egypt Soc Parasitol 2013 Apr; 43(1):147-66.</li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Anthrax is the plague of the ancient world and its existence is confirmed by the Roman poet Virgil. Also it is a threat in the modern world as it can be used in biological wars and bioterrorism. Anthrax is caused by Bacillus anthracis an unmovable, aerobic, gram-positive rod. It forms spores, which can survive for years in the environment. Three clinical forms result after exposure to anthrax spores: cutaneous, respiratory, and gastro- intestinal. The cutaneous anthrax commonly prevails among humans. The respiratory form occurs most likely due to inhalation of the bacterial spores, whereas the gastrointestinal form happens after spores' ingestion. Prophylactic, early diagnosis and proper treatment will reduce mortalities of anthrax. Thus, the physicians, senior nurses and individuals at risk should be aware of the danger of this disease.</div></div></div></description></item><item><title>Diagnostic approaches for rift valley Fever.</title><link>http://www.unboundmedicine.com/medline/citation/23689885/Diagnostic_approaches_for_rift_valley_Fever_</link><description><div class="result"><ul><li class="author">Wilson WC, Weingartl HM, Drolet BS, et al. </li><li class="title"><a href="./citation/23689885/Diagnostic_approaches_for_rift_valley_Fever_">Diagnostic approaches for rift valley Fever.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Developments in biologicals">Dev Biol (Basel) 2013.:73-8.</li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Disease outbreaks caused by arthropod-borne animal viruses (arboviruses) resulting in significant livestock and economic losses world-wide appear to be increasing. Rift Valley fever (RVF) virus is an important arbovirus that causes lethal disease in cattle, camels, sheep and goats in Sub-Saharan Africa. There is concern that this virus could spread because of global warming, increased animal trade or through bioterrorism. This paper discusses the current and developing approaches to diagnosis of RVF. Diagnostic assays are available for RVF, but availability can be limited and there is a need for global harmonization. Continued improvement of standard serological and viral genome amplification approaches, including new embedded/syndromic testing, biosensor, emerging virus detection and characterization technologies is needed. Copyright © 2013 by the International Alliance for Biological Standardization (IABS), Carouge-Geneva (Switzerland).</div></div></div></description></item><item><title>The Use of Colorimetric Sensor Arrays to Discriminate between Pathogenic Bacteria.</title><link>http://www.unboundmedicine.com/medline/citation/23671629/The_Use_of_Colorimetric_Sensor_Arrays_to_Discriminate_between_Pathogenic_Bacteria_</link><description><div class="result"><ul><li class="author">Lonsdale CL, Taba B, Queralto N, et al. </li><li class="title"><a href="./citation/23671629/The_Use_of_Colorimetric_Sensor_Arrays_to_Discriminate_between_Pathogenic_Bacteria_">The Use of Colorimetric Sensor Arrays to Discriminate between Pathogenic Bacteria.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="PloS one">PLoS One 2013; 8(5):e62726.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23671629/">PMC Free Full Text</span><span class="fulltext" data-link="http://dx.plos.org/10.1371/journal.pone.0062726">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">A colorimetric sensor array is a high-dimensional chemical sensor that is cheap, compact, disposable, robust, and easy to operate, making it a good candidate technology to detect pathogenic bacteria, especially potential bioterrorism agents like Yersinia pestis and Bacillus anthracis which feature on the Center for Disease Control and Prevention's list of potential biothreats. Here, a colorimetric sensor array was used to continuously monitor the volatile metabolites released by bacteria in solid media culture in an Advisory Committee on Dangerous Pathogen Containment Level 3 laboratory. At inoculum concentrations as low as 8 colony-forming units per plate, 4 different bacterial species were identified with 100% accuracy using logistic regression to classify the kinetic profile of sensor responses to culture headspace gas. The sensor array was able to further discriminate between different strains of the same species, including 5 strains of Yersinia pestis and Bacillus anthracis. These preliminary results suggest that disposable colorimetric sensor arrays can be an effective, low-cost tool to identify pathogenic bacteria.</div></div></div></description></item><item><title>Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5'-Monophosphate Dehydrogenase.</title><link>http://www.unboundmedicine.com/medline/citation/23668331/Optimization_of_Benzoxazole_Based_Inhibitors_of_Cryptosporidium_parvum_Inosine_5'_Monophosphate_Dehydrogenase_</link><description><div class="result"><ul><li class="author">Gorla SK, Kavitha M, Zhang M, et al. </li><li class="title"><a href="./citation/23668331/Optimization_of_Benzoxazole_Based_Inhibitors_of_Cryptosporidium_parvum_Inosine_5'_Monophosphate_Dehydrogenase_">Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5'-Monophosphate Dehydrogenase.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Journal of medicinal chemistry">J Med Chem 2013 May 23; 56(10):4028-4043.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1021/jm400241j">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Cryptosporidium parvum is an enteric protozoan parasite that has emerged as a major cause of diarrhea, malnutrition, and gastroenteritis and poses a potential bioterrorism threat. C. parvum synthesizes guanine nucleotides from host adenosine in a streamlined pathway that relies on inosine 5'-monophosphate dehydrogenase (IMPDH). We have previously identified several parasite-selective C. parvum IMPDH (CpIMPDH) inhibitors by high-throughput screening. In this paper, we report the structure-activity relationship (SAR) for a series of benzoxazole derivatives with many compounds demonstrating CpIMPDH IC50 values in the nanomolar range and &gt;500-fold selectivity over human IMPDH (hIMPDH). Unlike previously reported CpIMPDH inhibitors, these compounds are competitive inhibitors versus NAD(+). The SAR study reveals that pyridine and other small heteroaromatic substituents are required at the 2-position of the benzoxazole for potent inhibitory activity. In addition, several other SAR conclusions are highlighted with regard to the benzoxazole and the amide portion of the inhibitor, including preferred stereochemistry. An X-ray crystal structure of a representative E·IMP·inhibitor complex is also presented. Overall, the secondary amine derivative 15a demonstrated excellent CpIMPDH inhibitory activity (IC50 = 0.5 ± 0.1 nM) and moderate stability (t1/2 = 44 min) in mouse liver microsomes. Compound 73, the racemic version of 15a, also displayed superb antiparasitic activity in a Toxoplasma gondii strain that relies on CpIMPDH (EC50 = 20 ± 20 nM), and selectivity versus a wild-type T. gondii strain (200-fold). No toxicity was observed (LD50 &gt; 50 μM) against a panel of four mammalian cells lines.</div></div></div></description></item><item><title>Safety and immunogenicity of IMVAMUNE(®) smallpox vaccine using different strategies for a post event scenario.</title><link>http://www.unboundmedicine.com/medline/citation/23664987/Safety_and_immunogenicity_of_IMVAMUNE_®__smallpox_vaccine_using_different_strategies_for_a_post_event_scenario_</link><description><div class="result"><ul><li class="author">Frey SE, Winokur PL, Salata RA, et al. </li><li class="title"><a href="./citation/23664987/Safety_and_immunogenicity_of_IMVAMUNE_®__smallpox_vaccine_using_different_strategies_for_a_post_event_scenario_">Safety and immunogenicity of IMVAMUNE(®) smallpox vaccine using different strategies for a post event scenario.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Vaccine">Vaccine 2013 May 9.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://linkinghub.elsevier.com/retrieve/pii/S0264-410X(13)00518-5">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract"><h3>INTRODUCTION:</h3> Reintroduction of Variola major as an agent of bioterrorism remains a concern. A shortened dosing schedule of Bavarian Nordic's (BN) IMVAMUNE(®) (modified vaccinia Ankara vaccine against smallpox) was compared to the currently recommended 0- and 28-day schedule for non-inferiority by evaluating the magnitude and kinetics of the immune responses. <h3>METHODS:</h3> Subjects were assigned to receive IMVAMUNE or placebo administered subcutaneously on Days 0 and 7, Days 0 and 28, or Day 0. Blood was collected for antibody and cell-mediated immune assays. Subjects were followed for safety for 12 months after last vaccination. <h3>RESULTS:</h3> The primary endpoint of this study was the geometric mean antibody titers (GMT) at 14 days post last vaccination. Of 208 subjects enrolled, 191 received vaccine (Group: 0+7, Group: 0+28 and Group: 0) and 17 received placebo. Moderate/severe systemic reactogenicity after any vaccination were reported by 31.1%, 25.4%, and 28.6% of the subjects for Group: 0+7, Group: 0+28, and Group: 0, respectively (Chi-square test, P=0.77). Based on BN's Plaque Reduction Assay GMTs, Group: 0+7 was non-inferior to Group: 0+28 at Day 4, 180, and 365 after the second vaccination. On Day 14, Group: 0+7 and Group: 0+28 GMT were 10.8 (CI: 9.0, 12.9) and 30.2 (CI: 22.1, 41.1), respectively. Based on BN's Enzyme-linked immunosorbent assay, the proportion of subjects with positive titers for Group: 0+28 was significantly greater than that for Group: 0+7 after second vaccination at Days 4 and 180. By Day 14 after the second dose, the IFN-γ enzyme-linked immunosorbent spot (ELISPOT) responses were similar for Group: 0+28 and Group: 0+7. <h3>CONCLUSION:</h3> Overall, a standard dose of IMVAMUNE (0.5mL of 1×10(8)TCID/mL) administered subcutaneously was safe and well tolerated. A second dose of IMVAMUNE at Day 28 compared to Day 7 provided greater antibody responses and the maximal number of responders. By Day 14 after the second dose, IFN-γ ELISPOT responses were similar for Group: 0+28 and Group: 0+7.</div></div></div></description></item><item><title>The Changing Nature and Scope of Public Health Emergencies in Response to Annual Flu.</title><link>http://www.unboundmedicine.com/medline/citation/23641729/The_Changing_Nature_and_Scope_of_Public_Health_Emergencies_in_Response_to_Annual_Flu_</link><description><div class="result"><ul><li class="author">Hodge JG </li><li class="title"><a href="./citation/23641729/The_Changing_Nature_and_Scope_of_Public_Health_Emergencies_in_Response_to_Annual_Flu_">The Changing Nature and Scope of Public Health Emergencies in Response to Annual Flu.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Biosecurity and bioterrorism : biodefense strategy, practice, and science">Biosecur Bioterror 2013 May 3.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://www.liebertonline.com/doi/abs/10.1089/bsp.2013.0022?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub=pubmed">Publisher Full Text</span><span class="fulltext" data-link="http://dx.doi.org/10.1089/bsp.2013.0022">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">The rapid spread of influenza during the 2012-13 season brought a series of public health challenges and corresponding response efforts. For decades, responses to annual flu have been undertaken routinely without extensive legal intervention. With the recent declaration of states of public health emergencies in Boston (January 9, 2013) and New York State (January 12, 2013), however, the legal baseline is changing. Propelled by a slate of state and local emergency declarations during the 2009-10 H1N1 pandemic, public officials are beginning to show cause for the issuance of formal emergency declarations in support of flu response efforts. The legal effects of these types of declarations are profound. Public and private actors are given significant, expedited public health powers. Scarce resources like vaccines can be more efficiently allocated. Laws relating to licensure, scope of practice, and liability can be effectively waived. Though originally conceptualized and once reserved for catastrophic, long-term health-related or bioterrorism events, public health emergency declarations are evolving to address temporary impacts on health care and public health services arising annually from flu outbreaks. This commentary explores the changing nature of public health emergencies and their current and potential impact on the provision of healthcare services in response to national or regional threats to the public's health.</div></div></div></description></item><item><title>Bioterrorism: Health sector alertness.</title><link>http://www.unboundmedicine.com/medline/citation/23633831/Bioterrorism:_Health_sector_alertness_</link><description><div class="result"><ul><li class="author">Pinto VN </li><li class="title"><a href="./citation/23633831/Bioterrorism:_Health_sector_alertness_">Bioterrorism: Health sector alertness.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Journal of natural science, biology, and medicine">J Nat Sci Biol Med 2013 Jan; 4(1):24-8.</li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">The global events of the last two decades indicate that the threat of biological warfare is not a myth, but a harsh reality. The successive outbreaks caused by newly recognized and resurgent pathogens and the risk that high-consequence pathogens might be used as bioterrorism agents amply demonstrate the need to enhance capacity in clinical and public health management of highly infectious diseases. This review article provides a concise overview of bioterrorism, the agents used, and measures to counteract it, with a relevant note on India's current scenario of surveillance systems, laboratory response network, and the need for preparedness.</div></div></div></description></item><item><title>Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis.</title><link>http://www.unboundmedicine.com/medline/citation/23633074/Electron_microscopy:_essentials_for_viral_structure_morphogenesis_and_rapid_diagnosis_</link><description><div class="result"><ul><li class="author">Zhang Y, Hung T, Song J, et al. </li><li class="title"><a href="./citation/23633074/Electron_microscopy:_essentials_for_viral_structure_morphogenesis_and_rapid_diagnosis_">Electron microscopy: essentials for viral structure, morphogenesis and rapid diagnosis.<span class="title-pubtype"> [Journal Article]</span></a></li><li class="source" title="Science China. Life sciences">Sci China Life Sci 2013 May; 56(5):421-30.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://dx.doi.org/10.1007/s11427-013-4476-2">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Electron microscopy (EM) should be used in the front line for detection of agents in emergencies and bioterrorism, on accounts of its speed and accuracy. However, the number of EM diagnostic laboratories has decreased considerably and an increasing number of people encounter difficulties with EM results. Therefore, the research on viral structure and morphologyant in EM diagnostic practice. EM has several technological advantages, and should be a fundamental tool in clinical diagnosis of viruses, particularly when agents are unknown or unsuspected. In this article, we review the historical contribution of EM to virology, and its use in virus differentiation, localization of specific virus antigens, virus-cell interaction, and viral morphogenesis. It is essential that EM investigations are based on clinical and comprehensive pathogenesis data from light or confocal microscopy. Furthermore, avoidance of artifacts or false results is necessary to exploit fully the advantages while minimizing its limitations.</div></div></div></description></item><item><title>Rapid and reliable detection of bacterial endospores in environmental samples by diagnostic electron microscopy combined with X-ray microanalysis.</title><link>http://www.unboundmedicine.com/medline/citation/23603002/Rapid_and_reliable_detection_of_bacterial_endospores_in_environmental_samples_by_diagnostic_electron_microscopy_combined_with_X_ray_microanalysis_</link><description><div class="result"><ul><li class="author">Laue M, Fulda G </li><li class="title"><a href="./citation/23603002/Rapid_and_reliable_detection_of_bacterial_endospores_in_environmental_samples_by_diagnostic_electron_microscopy_combined_with_X_ray_microanalysis_">Rapid and reliable detection of bacterial endospores in environmental samples by diagnostic electron microscopy combined with X-ray microanalysis.<span class="title-pubtype"> [JOURNAL ARTICLE]</span></a></li><li class="source" title="Journal of microbiological methods">J Microbiol Methods 2013 Apr 17; 94(1):13-21.</li><li class="links"><span class="abstractButton">Abstract</span><span class="fulltext" data-link="http://linkinghub.elsevier.com/retrieve/pii/S0167-7012(13)00133-4">Publisher Full Text</span></li></ul><div class="abstract-wrapper" style="display: none;"><div class="abstract">Diagnostic negative staining electron microscopy is a front-line method for the rapid investigation of environmental and clinical samples in emergency situations caused by bioterrorism or outbreaks of an infectious disease. Spores of anthrax are one of the diagnostic targets in case of bioterrorism, because they have been used as a bio-weapon in the past and their production and transmission are rather simple. With negative staining electron microscopy bacterial spores can be identified based on their morphology at the single cell level. However, because of their particular density, no internal structures are visible which sometimes makes it difficult to distinguish spores from particles with a similar size and shape that are frequently present in environmental samples. Spores contain a high concentration of calcium ions besides other elements, which may allow a proper discrimination of spores from other suspicious particles. To investigate this hypothesis, negative staining electron microscopy, using either transmission or scanning electron microscopes, was combined with energy dispersive X-ray microanalysis, which reveals the element content of individual nanoparticles. A peak pattern consisting of calcium, sulphur and phosphorus was found as a typical signature within the X-ray spectrum of spores in various Clostridium and Bacillus species, including all strains of anthrax (Bacillus anthracis) tested. Moreover, spores could be reliably identified by this combined approach in environmental samples, like household products, soil or various presumed bioterrorist samples. In summary, the use of X-ray spectroscopy, either directly in the transmission electron microscope, or in a correlative approach by using scanning electron microscopy, improves the emergency diagnostics of suspicious environmental samples.</div></div></div></description></item></channel></rss>